Comparison of Planned and Actual costs related to Investigational Medical Products in Clinical Trials
Autor: | Taji Heravi, A, Henn, A, Deuster, S, Gloy, V, Mitter, V, Briel, M |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: | |
Zdroj: | Nützliche patientenrelevante Forschung; 21. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin; 20200213-20200215; Basel, Schweiz; DOC20ebmS4-V1-04 /20200212/ |
DOI: | 10.3205/20ebm020 |
Popis: | Background/research question: Conducting high quality randomized clinical trials (RCTs) is challenging and costly. Particularly investigator-initiated RCTs (IICTs) are often not completed as planned. The intervention under investigation is obviously an essential component of a clinical trial contributing[for full text, please go to the a.m. URL] Nützliche patientenrelevante Forschung; 21. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin |
Databáze: | OpenAIRE |
Externí odkaz: |